Navigation Links
Mechanical Device Helps Kids Waiting for Heart Transplant
Date:8/8/2012

ildren on ECMO had died after coming off the device. At 174 days, 88 percent of the children on the assist device were able to survive to transplantation or be weaned off the machine.

The average age in the second group of children was about 9 years old. The longest duration of support with the pediatric ventricular assist device was 192 days, compared with 28 days for ECMO. At 30 days, 33 percent of children on ECMO had died; at 192 days, only 8 percent of children on the assist device had died.

The pediatric ventricular assist device isn't a panacea. It carries significant risks of major bleeding, infection and strokes, according to the study.

"This is definitely not something to be undertaken with light consideration," Fraser said. "But for those desperate children who likely wouldn't survive to transplant, clearly the benefits of the device outweigh the risks."

Fraser added that children who receive the pediatric ventricular assist device can usually be taken off mechanical ventilation. They can typically get out of bed and move around, take part in physical therapy and eat normally. All of these things help make them stronger and healthier before surgery.

"This device is designed to rescue children whose hearts are failing so severely that the benefits outweigh the risk," said Dr. Daphne Hsu, chief of pediatric cardiology at Children's Hospital at Montefiore, in New York City.

She has experience with the device, and said "it's wonderful that there is a device to treat children now. There has not been much emphasis on treating heart failure in children."

The only drawback for the new device compared to ECMO is cost, she said. Although she didn't know the exact figures, she thought the new device initially cost about $50,000, compared with several thousand dollars for ECMO. But, she said, the cost of the assist device may have already come down, and might come down further as it gains more widespread use.

M
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Mechanical tissue resuscitation technology shows promise
2. Unprecedented accuracy in locating brain electrical activity with new device
3. Cell-Based Tracking Devices Might Help Monitor Treatments
4. Device converting images into music helps individuals without vision reach for objects in space
5. New Home Energy Savings Device Poised to Help Thousands Succeed Working from Home
6. Corporate Whistle Blower Center Now Urges Medical Device Insiders To Be A Whistleblower If They Can Prove The Device Maker Knew Of A Failure & Said Nothing=Huge Rewards
7. Vygone Presents a Revolutionary Electro Waveform Device to Help Treat Molluscum Contagiosum Lesions
8. Magnets in iPad2 May Alter Settings on Brain Shunt Devices: Study
9. Popularity Causing Several Week Lag In Delivery Of 'Plug In' Device To Start Saving On Electricity Between 8% and 20%
10. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
11. Adena Delivers Instant Health Information to Mobile Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mechanical Device Helps Kids Waiting for Heart Transplant
(Date:3/31/2015)... The Oliver Law Group P.C. has ... to client requests after Zofran lawsuits were filed in ... (GSK) failed to warn physicians and their patients about ... and “illegally and fraudently” promoted Zofran as a treatment ... for that use from the U.S. Food and Drug ...
(Date:3/31/2015)... The status of more than 1,000 ... Case Management Conference scheduled to be held in the ... April 21st. According to court documents, the jurisdiction is ... Mirena lawsuits filed on behalf of women who allegedly ... related to the birth control device. (In re: Mirena ...
(Date:3/31/2015)... Rising rates of anterior cruciate ligament ... surgeons to better analyze and investigate ways to improve ... A recent study published online in Sports ... 1,016 young, very active patients to compare ACL failure ... is the first review to examine young, active patients ...
(Date:3/31/2015)... These two automakers will address an ... They will highlight a shift that has become apparent ... a business proposition for the insurance carriers alone. With ... opportunities that lie in store for them. ... are now alive to their own involvement in the ...
(Date:3/31/2015)... 31, 2015 April is Parkinson’s disease Awareness ... to announce 30 Days, 30 Ways to Make a Difference. ... campaign that will offer a new action each day throughout ... those who battle this disease. , Every nine ... April alone nearly 5,000 individuals in this country will learn ...
Breaking Medicine News(10 mins):Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 3Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3Health News:ACL Failure Risks Increased in Young Patients Using Allografts 2Health News:TU-Automotive: Fiat and Renault-Nissan at the Centre of a Motor Insurance Evolution 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3
... million Series A financing from Alta Partners, ... ProQuest Investments and RiverVest Venture Partners, CARLSBAD, ... Pharmaceuticals, Inc. (Nasdaq: ISIS ) and Excaliard ... and develop antisense,drugs for the local treatment of ...
... granted the International HIDO ... and GOLFE JUAN, France, Nov. 27 Today, ... and health,product innovations and HIDO, the Humanitarian International ... HIDO,International Design Award. The Award was granted for ...
... 27 ,Awake, the movie is a,psychological thriller that tells ... himself awake and aware, but paralyzed,during heart surgery., It ... terrified,the American public,s imagination. ,Coma, is the gripping story of ... never wake up again., "Five years after the book ...
... Sosei Group Corporation,("Sosei"; TSE Mothers Index: 4565), ... status of its collaborative project SD118, which,is under ... has,commenced a multiple dose ascending Phase I study ... to explore higher doses has been extended., ...
... teeth and the presence of alopecia areata or localized alopecia, ... Alopecia areata starts with bald patches on the scalp, and ... and females of all ages, and experts believe that it ... Antonio Gil Montoya and Antonio Cutando Soriano, of the ...
... Endemic cholera, a potentially fatal,diarrheal disease found in ... by orally vaccinating half of the affected,populations once ... according to,new findings by an international team of ... biostatistician in the Vaccine and Infectious Disease,Institute at ...
Cached Medicine News:Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 2Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 4Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 5Health News:Cooler Solutions' 'Dignity Toilet' Wins International Design Competition by Providing Sanitation for Those in Need 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 3Health News:Sosei Announces Update on Phase I Trials for SD118 2Health News:Sosei Announces Update on Phase I Trials for SD118 3Health News:Infection outbreaks on teeth can cause 'alopecia areata' or localized hair loss 2Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 2Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 3
(Date:3/31/2015)... PGI has announced an expansion of its ... at its San Luis Potosi, ... expansion is centered on solving the challenge of complicated ... personal care product manufacturers. The planned ... and packaging, will allow customers to take advantage of ...
(Date:3/31/2015)... , March 31, 2015  InMed Pharmaceuticals Inc. ... biopharmaceutical company that specializes in developing safer, more ... Paul C. Anderson , Ph.D., to its ... industry veteran who brings significant drug discovery and ... is a synthetic organic chemist by training with ...
(Date:3/31/2015)... March 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated ... overall US market for Propafenone Hydrochloride 150mg, 225mg and ... Health. Arthur S. Przybyl , President ... announce the launch of our fourth product from the ...
Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
... ofatumumab has activity in heavily pre-treated patients who have ... , PHILADELPHIA, Dec. 8 ... positive results from a pivotal trial pre-planned interim analysis ... lymphocytic leukemia (CLL). The results demonstrate the potential of ...
... Dec. 8 Alexion Pharmaceuticals,Inc. (Nasdaq: ... from AEGIS, an open-label,registration study examining Soliris(R) ... hemoglobinuria (PNH). The pre-specified,primary efficacy endpoint of ... 86,percent reduction (P<0.001). Key secondary endpoints including ...
Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
Bimod, acetabular cup "Xl" UHMWHDPE....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Duraloc acetabular cup system....
Medicine Products: